330 related articles for article (PubMed ID: 25113877)
1. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
3. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.
Wei G; Luan W; Wang S; Cui S; Li F; Liu Y; Liu Y; Cheng M
Org Biomol Chem; 2015 Feb; 13(5):1507-14. PubMed ID: 25476168
[TBL] [Abstract][Full Text] [Related]
4. Multidimensional optimization of promising antitumor xanthone derivatives.
Azevedo CM; Afonso CM; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Corrêa AG; Reis S; Pinto MM
Bioorg Med Chem; 2013 Jun; 21(11):2941-59. PubMed ID: 23623253
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives.
Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P
J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer potential of novel xanthone derivatives with 3,6-substituted chains.
Liu C; Zhang M; Zhang Z; Zhang SB; Yang S; Zhang A; Yin L; Swarts S; Vidyasagar S; Zhang L; Okunieff P
Bioorg Med Chem; 2016 Sep; 24(18):4263-4271. PubMed ID: 27448774
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
8. Influence of New Synthetic Xanthones on the Proliferation and Migration Potential of Cancer Cell Lines In Vitro.
Szkaradek N; Sypniewski D; Żelaszczyk D; Gałka S; Borzdziłowska P; Marona H; Bednarek I
Anticancer Agents Med Chem; 2019; 19(16):1949-1965. PubMed ID: 30950354
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
Xue DQ; Zhang XY; Wang CJ; Ma LY; Zhu N; He P; Shao KP; Chen PJ; Gu YF; Zhang XS; Wang CF; Ji CH; Zhang QR; Liu HM
Eur J Med Chem; 2014 Oct; 85():235-44. PubMed ID: 25086915
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, SAR and biological evaluation of natural and non-natural hydroxylated and prenylated xanthones as antitumor agents.
Zhang X; Li X; Ye S; Zhang Y; Tao L; Gao Y; Gong D; Xi M; Meng H; Zhang M; Gao W; Xu X; Guo Q; You Q
Med Chem; 2012 Nov; 8(6):1012-25. PubMed ID: 22779801
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS.
Cheng JH; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Eur J Med Chem; 2011 Apr; 46(4):1222-31. PubMed ID: 21345544
[TBL] [Abstract][Full Text] [Related]
13. Recent cancer drug development with xanthone structures.
Na Y
J Pharm Pharmacol; 2009 Jun; 61(6):707-12. PubMed ID: 19505360
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel soluble 2,5-diketopiperazine derivatives as potential anticancer agents.
Liao S; Qin X; Li D; Tu Z; Li J; Zhou X; Wang J; Yang B; Lin X; Liu J; Yang X; Liu Y
Eur J Med Chem; 2014 Aug; 83():236-44. PubMed ID: 24960627
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.
Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S
Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents.
Chen JN; Wang XF; Li T; Wu DW; Fu XB; Zhang GJ; Shen XC; Wang HS
Eur J Med Chem; 2016 Jan; 107():12-25. PubMed ID: 26560049
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
Huang XC; Jin L; Wang M; Liang D; Chen ZF; Zhang Y; Pan YM; Wang HS
Eur J Med Chem; 2015 Jan; 89():370-85. PubMed ID: 25462253
[TBL] [Abstract][Full Text] [Related]
18. Studies on chemical modification and biology of a natural product, gambogic acid (II): Synthesis and bioevaluation of gambogellic acid and its derivatives from gambogic acid as antitumor agents.
Wang J; Ma J; You Q; Zhao L; Wang F; Li C; Guo Q
Eur J Med Chem; 2010 Sep; 45(9):4343-53. PubMed ID: 20605273
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents.
Taşdemir D; Karaküçük-İyidoğan A; Ulaşli M; Taşkin-Tok T; Oruç-Emre EE; Bayram H
Chirality; 2015 Feb; 27(2):177-88. PubMed ID: 25399965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]